Mirum Pharmaceuticals, Inc. ( MIRM) - Key Metrics
MIRM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $2.97 | -$0.11 | $0.12 | $0.11 |
| 2025Q3 | $2.29 | $0.05 | $0.68 | $0.68 |
| 2025Q2 | $2.57 | -$0.12 | $0.24 | $0.24 |
| 2025Q1 | $2.28 | -$0.30 | -$0.04 | -$0.04 |
MIRM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -173.00 |
| 2025Q3 | ? | 366.56 |
| 2025Q2 | ? | -107.94 |
| 2025Q1 | ? | -37.52 |
MIRM
Price: $101
52 week price:
Earnings Per Share: -13.60 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 266732
Market Capitalization: 4.6 billion